BR112022005324A2 - Composição farmacêutica, e, líquido iônico responsivo à temperatura - Google Patents

Composição farmacêutica, e, líquido iônico responsivo à temperatura

Info

Publication number
BR112022005324A2
BR112022005324A2 BR112022005324A BR112022005324A BR112022005324A2 BR 112022005324 A2 BR112022005324 A2 BR 112022005324A2 BR 112022005324 A BR112022005324 A BR 112022005324A BR 112022005324 A BR112022005324 A BR 112022005324A BR 112022005324 A2 BR112022005324 A2 BR 112022005324A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
temperature
ionic liquid
responsive ionic
responsive
Prior art date
Application number
BR112022005324A
Other languages
English (en)
Portuguese (pt)
Inventor
Masafumi Sudo
Mikito Hirakata
Suguru Takaki
Takahiro Motoshiromizu
Yuri Kajiwara
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of BR112022005324A2 publication Critical patent/BR112022005324A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112022005324A 2019-10-11 2020-10-08 Composição farmacêutica, e, líquido iônico responsivo à temperatura BR112022005324A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019187274 2019-10-11
PCT/JP2020/038097 WO2021070893A1 (ja) 2019-10-11 2020-10-08 温度応答性イオン液体を含む医薬組成物

Publications (1)

Publication Number Publication Date
BR112022005324A2 true BR112022005324A2 (pt) 2022-06-14

Family

ID=75437270

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022005324A BR112022005324A2 (pt) 2019-10-11 2020-10-08 Composição farmacêutica, e, líquido iônico responsivo à temperatura

Country Status (9)

Country Link
US (1) US20240058452A1 (https=)
EP (1) EP4043007A4 (https=)
JP (1) JP7322895B2 (https=)
KR (1) KR20220080076A (https=)
CN (1) CN114502142B (https=)
AU (1) AU2020362643B2 (https=)
BR (1) BR112022005324A2 (https=)
CA (1) CA3157143A1 (https=)
WO (1) WO2021070893A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024106024A1 (https=) * 2022-11-14 2024-05-23

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1705640A (zh) * 2002-08-16 2005-12-07 塞克姆公司 包含磺酸根阴离子的离子液体
US20060094616A1 (en) * 2004-11-01 2006-05-04 Hecht Stacie E Ionic liquids derived from surfactants
JP4969065B2 (ja) 2005-07-13 2012-07-04 株式会社 メドレックス 常温性イオン性液体を含有する医薬組成物
JP2008044849A (ja) * 2006-08-10 2008-02-28 Tokyo Univ Of Agriculture & Technology 温度制御により水と可逆的に相溶/相分離を示すイオン液体
US20100029704A1 (en) * 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
AU2008327436B2 (en) * 2007-11-22 2013-09-05 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
EP2233138B1 (en) * 2007-12-11 2014-07-23 Medrx Co., Ltd. Tape preparation comprising etodolac in ionic liquid form
JP2009178617A (ja) * 2008-01-29 2009-08-13 Sanyo Chem Ind Ltd 熱応答性液体組成物
WO2009119836A1 (ja) * 2008-03-28 2009-10-01 アンジェスMg株式会社 転写因子デコイを有効成分とする外用剤組成物
WO2010078300A1 (en) * 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Dual functioning ionic liquids and salts thereof
EP2744335B1 (en) * 2011-08-16 2018-10-10 Basf Se Composition comprising active ingredient, oil and ionic liquid
WO2014024896A1 (ja) * 2012-08-08 2014-02-13 株式会社メドレックス アゴメラチンを含有する貼付剤組成物
JPWO2015129527A1 (ja) * 2014-02-27 2017-03-30 株式会社 メドレックス プラミペキソールを含有する神経変性疾患の治療用貼付剤
CN105363360A (zh) * 2014-08-26 2016-03-02 中国科学院大连化学物理研究所 一种温度刺激响应智能化的微乳液体系及其应用
EP3395368A1 (en) 2014-10-30 2018-10-31 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid
EP3251697A4 (en) * 2015-01-27 2018-08-22 Ajinomoto Co., Inc. Method for controlling skin penetration
CN106420610B (zh) * 2016-10-21 2019-06-11 昆明理工大学 一种离子液体微乳及其应用
CN109896992A (zh) * 2017-12-08 2019-06-18 武汉软件工程职业学院 制备离子液体的方法及其应用

Also Published As

Publication number Publication date
AU2020362643B2 (en) 2024-12-12
EP4043007A4 (en) 2023-11-08
JP7322895B2 (ja) 2023-08-08
CA3157143A1 (en) 2021-04-15
JPWO2021070893A1 (https=) 2021-04-15
WO2021070893A1 (ja) 2021-04-15
US20240058452A1 (en) 2024-02-22
EP4043007A1 (en) 2022-08-17
CN114502142B (zh) 2023-05-09
CN114502142A (zh) 2022-05-13
AU2020362643A1 (en) 2022-05-05
KR20220080076A (ko) 2022-06-14

Similar Documents

Publication Publication Date Title
BR112022012911A2 (pt) Instrumento cirúrgico que compreende um sistema de controle responsivo a configurações de software
MA43709A (fr) Composition pharmaceutique comprenant de l'empagliflozine et ses utilisations
BR112015019440A2 (pt) métodos e dispositivos para fortalecimento da pele
BR112015023650A2 (pt) dispositivos, sistemas, e métodos para distribuição percutânea de componentes
BR112016017193A2 (pt) Derivados de insulina, seus usos, e composição farmacêutica
BR112018010018A2 (pt) moduladores de ror-gama
BR112019021308A8 (pt) Curativos extensíveis
MX2025014414A (es) Composiciones de éster de ácido cannabinoide y sus usos
BR112016014876A2 (pt) composto que modula a quantidade ou a atividade de gibspla2, composição farmacêutica, imunógeno que induz uma resposta imune anti-gibspla2, composição de vacina, método para o diagnóstico da imunodeficiência humana associada com a alteração de células t, e, método para a produção de gibspla2
CL2019001586A1 (es) Insulina que contiene composiciones farmacéuticas.
EP3498279A4 (en) PHARMACEUTICAL COMPOSITION WITH AMODIAQUIN AND ANTIDIABETIC MEDICINAL PRODUCT AS AN ACTIVE SUBSTANCE FOR PREVENTING OR TREATING DIABETES
AR106364A1 (es) Derivados de insulina y sus usos médicos
BR112017004056A2 (pt) composições e métodos para detecção da proteína smn em um indivíduo e tratamento de um indivíduo
BR112019024566A2 (pt) inibidores de pirazol magl
EP3603804A4 (en) Preparation and application of 4-methyl-5-vinylthiazolyl polymeric ionic liquid
MX2019001579A (es) Composiciones farmaceuticas que comprenden inhibidores de la proteina quinasa akt.
BR112022005324A2 (pt) Composição farmacêutica, e, líquido iônico responsivo à temperatura
BR112019021335A8 (pt) Curativos extensíveis
EP3330678A4 (en) DEVICE FOR MEASURING THE CONSUMPTION QUANTITY AND DETERMINING THE FLOWING OR GAS FLOWING DEVICE
EP3582759A4 (en) BIOEQUIVALENT PHARMACEUTICAL COMPOSITION OF PRE-ORDIOXETINE HYDROBROMIDE
MA45158A (fr) Composition pharmaceutique comprenant de l'éteplirsen
DK3949971T3 (da) Anvendelse af luteolin-7-O-glucosid eller luteolin-7-O-glucuronid til fremstilling af medicin til øjenskader
BR112021009616A8 (pt) Composição cicatrizante que compreende água eletrolisada e máscara de aplicação cutânea
EP3880183A4 (en) PHARMACEUTICAL PREPARATION OF FRUQUINTINIB AND USE THEREOF
EP3872907A4 (en) FOIL AND MANUFACTURING PROCESS

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]